1. 44P In situ CAR therapy using oRNA™ lipid nanoparticles regresses tumors in mice. (December 2022) Authors: Mabry, R.; Becker, A.; Wesselhoeft, A.; Horhata, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗